1. Bupropion: risk of serotonin syndrome

   News item 28 November 2020 Pages: 1 - 1

2. Clarification on Canadian considerations in risk management plans

   News item 28 November 2020 Pages: 2 - 2

3. Dimethyl fumarate information updated to include ways to minimise PML

   News item 28 November 2020 Pages: 3 - 3

4. EMA recommendations on nitrosamine impurities in sartans

   News item 28 November 2020 Pages: 4 - 4

5. EMA recommends restricting use of ulipristal: risk of liver injury

   News item 28 November 2020 Pages: 5 - 5

6. EMA's safety monitoring plan for COVID-19 vaccines

   News item 28 November 2020 Pages: 6 - 6

7. HSA warns of atezolizumab-related SCARs, SJS and TEN

   News item 28 November 2020 Pages: 7 - 7

8. MHRA reviewing isotretinoin-related psychiatric and sexual disorders

   News item 28 November 2020 Pages: 8 - 8

9. Risk of congenital malformations with modafinil

   News item 28 November 2020 Pages: 9 - 9

10. Risk of hypophosphataemia with ferric carboxymaltose

    News item 28 November 2020 Pages: 10 - 10

11. Updated recommendations regarding Gilenya-induced liver injury

    News item 28 November 2020 Pages: 11 - 11

12. Cardiovascular outcomes with endocrine therapy

    Clinical study 28 November 2020 Pages: 12 - 12

13. Finasteride: suicidality or psychological adverse events

    Clinical study 28 November 2020 Pages: 13 - 13

14. New basal insulins in T2DM: cost not increased, hypoglycaemia reduced

    Clinical study 28 November 2020 Pages: 14 - 14

15. Other adverse reaction research

    News item 28 November 2020 Pages: 15 - 15

16. Acetazolamide

    Case report 28 November 2020 Pages: 16 - 16

17. Aciclovir overdose

    Case report 28 November 2020 Pages: 17 - 17

18. Aciclovir/ceftriaxone/ustekinumab

    Case report 28 November 2020 Pages: 18 - 18

19. Adalimumab

    Case report 28 November 2020 Pages: 19 - 19

20. Adalimumab/infliximab/tioguanine

    Case report 28 November 2020 Pages: 20 - 20

21. Alectinib/crizotinib

    Case report 28 November 2020 Pages: 21 - 21

22. Alemtuzumab

    Case report 28 November 2020 Pages: 22 - 22

23. Alemtuzumab/busulfan/fludarabine

    Case report 28 November 2020 Pages: 23 - 23

24. Alemtuzumab/methylprednisolone

    Case report 28 November 2020 Pages: 24 - 24

25. Alendronic-acid/dapsone/prednisolone

    Case report 28 November 2020 Pages: 25 - 25

26. Allopurinol

    Case report 28 November 2020 Pages: 26 - 26

27. Alprazolam/phenobarbital

    Case report 28 November 2020 Pages: 27 - 27

28. Alprostadil

    Case report 28 November 2020 Pages: 28 - 28

29. Amikacin

    Case report 28 November 2020 Pages: 29 - 29

30. Amikacin/gentamicin

    Case report 28 November 2020 Pages: 30 - 30

31. Amiodarone

    Case report 28 November 2020 Pages: 31 - 31

32. Amiodarone/mexiletine

    Case report 28 November 2020 Pages: 32 - 32

33. Amoxicillin/ceftriaxone

    Case report 28 November 2020 Pages: 33 - 33

34. Amoxicillin/clavulanic-acid

    Case report 28 November 2020 Pages: 34 - 34

35. Amoxicillin/clavulanic-acid/clomifene

    Case report 28 November 2020 Pages: 35 - 35

36. Amphotericin B liposomal/antihyperglycaemics/itraconazole

    Case report 28 November 2020 Pages: 36 - 36

37. Anti-epileptics/general-anaesthetics

    Case report 28 November 2020 Pages: 37 - 37

38. Antibacterials/omeprazole/pantoprazole

    Case report 28 November 2020 Pages: 38 - 38

39. Antidepressants/donepezil/valproate-semisodium

    Case report 28 November 2020 Pages: 39 - 39

40. Antiepileptic drugs

    Case report 28 November 2020 Pages: 40 - 40

41. Antiepileptic-drugs

    Case report 28 November 2020 Pages: 41 - 41

42. Antilymphocyte-globulin/immunosuppressants

    Case report 28 November 2020 Pages: 42 - 42

43. Antineoplastics

    Case report 28 November 2020 Pages: 43 - 43

44. Antineoplastics

    Case report 28 November 2020 Pages: 44 - 44

45. Antineoplastics

    Case report 28 November 2020 Pages: 45 - 45

46. Antineoplastics

    Case report 28 November 2020 Pages: 46 - 46

47. Antineoplastics

    Case report 28 November 2020 Pages: 47 - 47

48. Antineoplastics

    Case report 28 November 2020 Pages: 48 - 48

49. Antineoplastics/enoxaparin sodium

    Case report 28 November 2020 Pages: 49 - 49

50. Antipsychotics

    Case report 28 November 2020 Pages: 50 - 50